Advertisement
UK markets close in 1 hour 21 minutes

  • FTSE 100

    8,132.85
    +53.99 (+0.67%)
     

  • FTSE 250

    19,823.64
    +221.66 (+1.13%)
     

  • AIM

    755.39
    +2.27 (+0.30%)
     

  • GBP/EUR

    1.1676
    +0.0020 (+0.17%)
     

  • GBP/USD

    1.2502
    -0.0009 (-0.07%)
     

  • Bitcoin GBP

    51,470.85
    +667.00 (+1.31%)
     

  • CMC Crypto 200

    1,337.69
    -58.85 (-4.21%)
     

  • S&P 500

    5,102.19
    +53.77 (+1.07%)
     

  • DOW

    38,282.81
    +197.01 (+0.52%)
     

  • CRUDE OIL

    83.95
    +0.38 (+0.45%)
     

  • GOLD FUTURES

    2,353.00
    +10.50 (+0.45%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     

  • DAX

    18,157.22
    +239.94 (+1.34%)
     

  • CAC 40

    8,094.85
    +78.20 (+0.98%)
     
PROPERTY:

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Orion Corporation's financial reporting and Annual General Meeting in 2023

Orion Oyj
·2-min read
Orion Oyj
Orion Oyj

ORION CORPORATION
STOCK EXCHANGE RELEASE – FINANCIAL CALENDAR    
15 JULY 2022 at 11.00 EEST

Orion Corporation's financial reporting and Annual General Meeting in 2023
 

Orion Corporation will publish its Financial Statement Release 2022 on Thursday, 9 February 2023.
The publication dates of the Interim Reports and the Half-Year Financial Report in 2023 are as follows:

Interim Report January-March 2023 
Half-Year Financial Report January-June 2023
Interim Report January-September 2023

 

Thursday, 27 April 2023
Monday, 17 July 2023
Thursday, 26 October 2023


The Financial Statements and the Report of the Board of Directors for 2022 will be published on the Company's website at the latest in week 9/2023.

ADVERTISEMENT

The Annual General Meeting is planned to be held on Wednesday, 22 March 2023.

Orion's financial reports and related presentation material are available on the Group's website at http://www.orion.fi/investors promptly after the publishing. The website also provides a possibility to register on Orion's mailing lists for releases.

Orion Corporation

Timo Lappalainen

President and CEO

   

Olli Huotari

SVP, Corporate Functions

 


Contact person:
Tuukka Hirvonen, Investor Relations, Orion Corporation
tel. +358 10 426 2721

Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
http://www.orion.fi/en
http://www.twitter.com/OrionCorpIR

Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are oncology and pain. Orion's net sales in 2021 amounted to EUR 1,041 million and the company had about 3,350 employees at the end of the year. Orion's A and B shares are listed on Nasdaq Helsinki.